Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016, Article ID 5457010, 11 pages
http://dx.doi.org/10.1155/2016/5457010
Research Article

In Vitro Effects of Some Botanicals with Anti-Inflammatory and Antitoxic Activity

1Division of Research and Development, SANYpet SpA, 35023 Bagnoli di Sopra, Italy
2School of Specialization in Clinical Biochemistry, “G. d’Annunzio” University, 66100 Chieti, Italy
3Department of Translational Medical Sciences, University of Naples Federico II, 80131 Naples, Italy
4Ph.D. School of Science, University of Basilicata, 85100 Potenza, Italy
5Department of Veterinary Medicine and Animal Productions, University of Naples Federico II, 80100 Naples, Italy
6Department of Science, University of Basilicata, 85100 Potenza, Italy

Received 31 May 2016; Revised 19 July 2016; Accepted 21 July 2016

Academic Editor: Giuseppe A. Sautto

Copyright © 2016 Gianandrea Guidetti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. J. Delves and I. M. Roitt, “The immune system. First of two parts,” The New England Journal of Medicine, vol. 343, no. 1, pp. 37–49, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Medzhitov, “Recognition of microorganisms and activation of the immune response,” Nature, vol. 449, no. 7164, pp. 819–826, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Hoebe, E. Janssen, and B. Beutler, “The interface between innate and adaptive immunity,” Nature Immunology, vol. 5, no. 10, pp. 971–974, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. C. A. Janeway Jr. and R. Medzhitov, “Innate immune recognition,” Annual Review of Immunology, vol. 20, pp. 197–216, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Iwasaki and R. Medzhitov, “Regulation of adaptive immunity by the innate immune system,” Science, vol. 327, no. 5963, pp. 291–295, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Romagnani, “TH1 and TH2 in human diseases,” Clinical Immunology and Immunopathology, vol. 80, no. 3, part 1, pp. 225–235, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. I. J. Crane and J. V. Forrester, “Th1 and Th2 lymphocytes in autoimmune disease,” Critical Reviews in Immunology, vol. 25, no. 2, pp. 75–102, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. K. M. Pollard, D. M. Cauvi, C. B. Toomey, K. V. Morris, and D. H. Kono, “Interferon-gamma and systemic autoimmunity,” Discovery Medicine, vol. 16, no. 87, pp. 123–131, 2013. View at Google Scholar · View at Scopus
  9. R. Baccala, D. H. Kono, and A. N. Theofilopoulos, “Interferons as pathogenic effectors in autoimmunity,” Immunological Reviews, vol. 204, pp. 9–26, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Funauchi, H. Sugishima, M. Minoda, and A. Horiuchi, “Serum level of interferon-gamma in autoimmune diseases,” Tohoku Journal of Experimental Medicine, vol. 164, no. 4, pp. 259–267, 1991. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Hertzog, S. Forster, and S. Samarajiwa, “Systems biology of interferon responses,” Journal of Interferon and Cytokine Research, vol. 31, no. 1, pp. 5–11, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Hu and L. B. Ivashkiv, “Cross-regulation of signaling pathways by interferon-γ: implications for immune responses and autoimmune diseases,” Immunity, vol. 31, no. 4, pp. 539–550, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Rönnblom and M.-L. Eloranta, “The interferon signature in autoimmune diseases,” Current Opinion in Rheumatology, vol. 25, no. 2, pp. 248–253, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Tang, G. C. Sharp, K. P. Peterson, and H. Braley-Mullen, “IFN-γ-deficient mice develop severe granulomatous experimental autoimmune thyroiditis with eosinophil infiltration in thyroids,” The Journal of Immunology, vol. 160, no. 10, pp. 5105–5112, 1998. View at Google Scholar · View at Scopus
  15. S. Yu, G. C. Sharp, and H. Braley-Mullen, “Dual roles for IFN-γ, but not for IL-4, in spontaneous autoimmune thyroiditis in NOD.H-2h4 mice,” The Journal of Immunology, vol. 169, no. 7, pp. 3999–4007, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. E. C. Baechler, P. K. Gregersen, and T. W. Behrens, “The emerging role of interferon in human systemic lupus erythematosus,” Current Opinion in Immunology, vol. 16, no. 6, pp. 801–807, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. K. M. Pollard, P. Hultman, and D. H. Kono, “Toxicology of autoimmune diseases,” Chemical Research in Toxicology, vol. 23, no. 3, pp. 455–466, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Dedeoglu, “Drug-induced autoimmunity,” Current Opinion in Rheumatology, vol. 21, no. 5, pp. 547–551, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C. D. Vedove, M. Del Giglio, D. Schena, and G. Girolomoni, “Drug-induced lupus erythematosus,” Archives of Dermatological Research, vol. 301, no. 1, pp. 99–105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. R. L. Rubin, “Drug-induced lupus,” Toxicology, vol. 209, no. 2, pp. 135–147, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Patterson and D. Germolec, “Toxic oil syndrome: review of immune aspects of the disease,” Journal of Immunotoxicology, vol. 2, no. 1, pp. 51–58, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. K. M. Pollard, P. Hultman, and D. H. Kono, “Immunology and genetics of induced systemic autoimmunity,” Autoimmunity Reviews, vol. 4, no. 5, pp. 282–288, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. M. L. Nelson and S. B. Levy, “The history of the tetracyclines,” Annals of the New York Academy of Sciences, vol. 1241, no. 1, pp. 17–32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. T. G. Marshall and F. E. Marshall, “Sarcoidosis succumbs to antibiotics-implications for autoimmune disease,” Autoimmunity Reviews, vol. 3, no. 4, pp. 295–300, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Lenert, M. Icardi, and L. Dahmoush, “ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review,” Clinical Rheumatology, vol. 32, no. 7, pp. 1099–1106, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. U. Christen and M. G. von Herrath, “Transgenic animal models for type 1 diabetes: linking a tetracycline-inducible promoter with a virus-inducible mouse model,” Transgenic Research, vol. 11, no. 6, pp. 587–595, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. S. M. Attar, “Tetracyclines: what a rheumatologist needs to know?” International Journal of Rheumatic Diseases, vol. 12, no. 2, pp. 84–89, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. A. K. Sarmah, M. T. Meyer, and A. B. A. Boxall, “A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment,” Chemosphere, vol. 65, no. 5, pp. 725–759, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Halling-Sørensen, G. Sengeløv, and J. Tjørnelund, “Toxicity of tetracyclines and tetracycline degradation products to environmentally relevant bacteria, including selected tetracycline-resistant bacteria,” Archives of Environmental Contamination and Toxicology, vol. 42, no. 3, pp. 263–271, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. W. D. Black, “A study in the pharmacodynamics of oxytetracycline in the chicken,” Poultry Science, vol. 56, no. 5, pp. 1430–1434, 1977. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Odore, M. De Marco, L. Gasco et al., “Cytotoxic effects of oxytetracycline residues in the bones of broiler chickens following therapeutic oral administration of a water formulation,” Poultry Science, vol. 94, no. 8, pp. 1979–1985, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Di Cerbo, A. T. Palatucci, V. Rubino et al., “Toxicological implications and inflammatory response in human lymphocytes challenged with oxytetracycline,” Journal of Biochemical and Molecular Toxicology, vol. 30, no. 4, pp. 170–177, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Di Cerbo, S. Canello, G. Guidetti, C. Laurino, and B. Palmieri, “Unusual antibiotic presence in gym trained subjects with food intolerance; a case report,” Nutricion Hospitalaria, vol. 30, no. 2, pp. 395–398, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. W. Andlauer and P. Fürst, “Nutraceuticals: a piece of history, present status and outlook,” Food Research International, vol. 35, no. 2-3, pp. 171–176, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. S.-A. Im, K.-H. Kim, H.-S. Kim et al., “Processed Aloe vera Gel ameliorates cyclophosphamide-induced immunotoxicity,” International Journal of Molecular Sciences, vol. 15, no. 11, pp. 19342–19354, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Djeraba and P. Quere, “In vivo macrophage activation in chickens with Acemannan, a complex carbohydrate extracted from Aloe vera,” International Journal of Immunopharmacology, vol. 22, no. 5, pp. 365–372, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Collard and S. Roy, “Improved function of diabetic wound-site macrophages and accelerated wound closure in response to oral supplementation of a fermented papaya preparation,” Antioxidants and Redox Signaling, vol. 13, no. 5, pp. 599–606, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Abdullah, P.-S. Chai, C.-Y. Loh et al., “Carica papaya increases regulatory T cells and reduces IFN-γ+CD4+ T cells in healthy human subjects,” Molecular Nutrition and Food Research, vol. 55, no. 5, pp. 803–806, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. T. T. T. Nguyen, P. N. Shaw, M.-O. Parat, and A. K. Hewavitharana, “Anticancer activity of Carica papaya: a review,” Molecular Nutrition and Food Research, vol. 57, no. 1, pp. 153–164, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. J. S. Lee, S.-Y. Park, D. Thapa et al., “Grifola frondosa water extract alleviates intestinal inflammation by suppressing TNF-α production and its signaling,” Experimental and Molecular Medicine, vol. 42, no. 2, pp. 143–154, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. K. R. Martin, “Both common and specialty mushrooms inhibit adhesion molecule expression and in vitro binding of monocytes to human aortic endothelial cells in a pro-inflammatory environment,” Nutrition Journal, vol. 9, article 29, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Masuda, A. Matsumoto, T. Toida, T. Oikawa, K. Ito, and H. Nanba, “Characterization and antitumor effect of a novel polysaccharide from Grifola frondosa,” Journal of Agricultural and Food Chemistry, vol. 57, no. 21, pp. 10143–10149, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Masuda, K. Ito, M. Konishi, and H. Nanba, “A polysaccharide extracted from Grifola frondosa enhances the anti-tumor activity of bone marrow-derived dendritic cell-based immunotherapy against murine colon cancer,” Cancer Immunology, Immunotherapy, vol. 59, no. 10, pp. 1531–1541, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Kodama, N. Harada, and H. Nanba, “A polysaccharide, extract from grifola frondosa, induces Th-1 dominant responses in carcinoma-bearing BALB/c mice,” Japanese Journal of Pharmacology, vol. 90, no. 4, pp. 357–360, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Arora, K. Shah, and S. Pandey-Rai, “Inhibition of imiquimod-induced psoriasis-like dermatitis in mice by herbal extracts from some Indian medicinal plants,” Protoplasma, vol. 253, no. 2, pp. 503–515, 2016. View at Publisher · View at Google Scholar
  46. V. Leray, B. Freuchet, J. Le Bloc'h, I. Jeusette, C. Torre, and P. Nguyen, “Effect of citrus polyphenol- and curcumin-supplemented diet on inflammatory state in obese cats,” The British Journal of Nutrition, vol. 106, supplement 1, pp. S198–S201, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Jain and E. Basal, “Inhibition of Propionibacterium acnes-induced mediators of inflammation by Indian herbs,” Phytomedicine, vol. 10, no. 1, pp. 34–38, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. G. G. L. Yue, B. C. L. Chan, P.-M. Hon et al., “Evaluation of in vitro anti-proliferative and immunomodulatory activities of compounds isolated from Curcuma longa,” Food and Chemical Toxicology, vol. 48, no. 8-9, pp. 2011–2020, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. N. M. Rogers, S. Kireta, and P. T. H. Coates, “Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo,” Clinical and Experimental Immunology, vol. 162, no. 3, pp. 460–473, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Huang, S. Cao, M. Nagamani, K. E. Anderson, J. J. Grady, and L.-J. W. Lu, “Decreased circulating levels of tumor necrosis factor-α in postmenopausal women during consumption of soy-containing isoflavones,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 7, pp. 3956–3962, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. B. K. Chacko, R. T. Chandler, A. Mundhekar et al., “Revealing anti-inflammatory mechanisms of soy isoflavones by flow: modulation of leukocyte-endothelial cell interactions,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 289, no. 2, pp. H908–H915, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Nagarajan, B. W. Stewart, and T. M. Badger, “Soy isoflavones attenuate human monocyte adhesion to endothelial cell-specific CD54 by inhibiting monocyte CD11a,” Journal of Nutrition, vol. 136, no. 9, pp. 2384–2390, 2006. View at Google Scholar · View at Scopus
  53. S. Yellayi, M. A. Zakroczymski, V. Selvaraj et al., “The phytoestrogen genistein suppresses cell-mediated immunity in mice,” Journal of Endocrinology, vol. 176, no. 2, pp. 267–274, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Wei, S. Bhatt, L. M. Chang, H. A. Sampson, and M. Masilamani, “Isoflavones, genistein and daidzein, regulate mucosal immune response by suppressing dendritic cell function,” PLoS ONE, vol. 7, no. 10, Article ID e47979, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Ghanim, C. L. Sia, S. Abuaysheh et al., “An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 9, p. -E8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. K. T. Noh, J. Cho, S. H. Chun et al., “Resveratrol regulates naïve CD 8+ T-cell proliferation by upregulating IFN-γ-induced tryptophanyl-tRNA synthetase expression,” BMB Reports, vol. 48, no. 5, pp. 283–288, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. I. Vouldoukis, D. Lacan, C. Kamate et al., “Antioxidant and anti-inflammatory properties of a Cucumis melo LC. extract rich in superoxide dismutase activity,” Journal of Ethnopharmacology, vol. 94, no. 1, pp. 67–75, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. J.-P. Lallès, D. Lacan, and J.-C. David, “A melon pulp concentrate rich in superoxide dismutase reduces stress proteins along the gastrointestinal tract of pigs,” Nutrition, vol. 27, no. 3, pp. 358–363, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. L. Cortese, M. Annunziatella, A. T. Palatucci et al., “An immune-modulating diet increases the regulatory T cells and reduces T helper 1 inflammatory response in Leishmaniosis affected dogs treated with standard therapy,” BMC Veterinary Research, vol. 11, article 295, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Di Cerbo, S. Centenaro, F. Beribè et al., “Clinical evaluation of an antiinflammatory and antioxidant diet effect in 30 dogs affected by chronic otitis externa: preliminary results,” Veterinary Research Communications, vol. 40, no. 1, pp. 29–38, 2016. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Di Cerbo, B. Palmieri, F. Chiavolelli, G. Guidetti, and S. Canello, “Functional foods in pets and humans,” The International Journal of Applied Research in Veterinary Medicine, vol. 12, no. 3, pp. 192–199, 2014. View at Google Scholar
  62. S. Sechi, F. Chiavolelli, N. Spissu et al., “An antioxidant dietary supplement improves brain-derived neurotrophic factor levels in serum of aged dogs: preliminary results,” Journal of Veterinary Medicine, vol. 2015, Article ID 412501, 9 pages, 2015. View at Publisher · View at Google Scholar
  63. A. Di Cerbo, F. Pezzuto, S. Canello, G. Guidetti, and B. Palmieri, “Therapeutic effectiveness of a dietary supplement for management of halitosis in dogs,” Journal of Visualized Experiments, vol. 2015, no. 101, article e52717, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. S. U. Kadam, C. P. O'Donnell, D. K. Rai et al., “Laminarin from Irish brown seaweeds Ascophyllum nodosum and Laminaria hyperborea: ultrasound assisted extraction, characterization and bioactivity,” Marine Drugs, vol. 13, no. 7, pp. 4270–4280, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. F.-W. Liu, F.-C. Liu, Y.-R. Wang, H.-I. Tsai, and H.-P. Yu, “Aloin protects skin fibroblasts from heat stress-induced oxidative stress damage by regulating the oxidative defense system,” PLoS ONE, vol. 10, no. 12, Article ID e0143528, 2015. View at Publisher · View at Google Scholar · View at Scopus
  66. B. Wang, J. Liu, and Z. Gong, “Resveratrol induces apoptosis in K562 cells via the regulation of mitochondrial signaling pathways,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 9, pp. 16926–16933, 2015. View at Google Scholar · View at Scopus
  67. S. Hayakawa, K. Saito, N. Miyoshi et al., “Anti-cancer effects of green tea by either anti- or pro-oxidative mechanisms,” Asian Pacific Journal of Cancer Prevention, vol. 17, no. 4, pp. 1649–1654, 2016. View at Google Scholar
  68. C. R. da Silva, M. B. N. Oliveira, E. S. Motta et al., “Genotoxic and cytotoxic safety evaluation of papain (Carica papaya L.) using in vitro assays,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 197898, 8 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. J. H. Lee, S.-R. Hwang, Y.-H. Lee, K. Kim, K. M. Cho, and Y. B. Lee, “Changes occurring in compositions and antioxidant properties of healthy soybean seeds [Glycine max (L.) Merr.] and soybean seeds diseased by Phomopsis longicolla and Cercospora kikuchii fungal pathogens,” Food Chemistry, vol. 185, pp. 205–211, 2015. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. Masuda, D. Nawa, Y. Nakayama, M. Konishi, and H. Nanba, “Soluble β-glucan from grifola frondosa induces tumor regression in synergy with TLR9 agonist via dendritic cell-mediated immunity,” Journal of Leukocyte Biology, vol. 98, no. 6, pp. 1015–1025, 2015. View at Publisher · View at Google Scholar · View at Scopus
  71. R. R. Ambati, S.-M. Phang, S. Ravi, and R. G. Aswathanarayana, “Astaxanthin: sources, extraction, stability, biological activities and its commercial applications—a review,” Marine Drugs, vol. 12, no. 1, pp. 128–152, 2014. View at Publisher · View at Google Scholar · View at Scopus
  72. D. J. Fast, J. A. Balles, J. D. Scholten, T. Mulder, and J. Rana, “Echinacea purpurea root extract inhibits TNF release in response to Pam3Csk4 in a phosphatidylinositol-3-kinase dependent manner,” Cellular Immunology, vol. 297, no. 2, pp. 94–99, 2015. View at Publisher · View at Google Scholar · View at Scopus
  73. Y. Deng, S. Sriwiriyajan, A. Tedasen, P. Hiransai, and P. Graidist, “Anti-cancer effects of Piper nigrum via inducing multiple molecular signaling in vivo and in vitro,” Journal of Ethnopharmacology, vol. 188, pp. 87–95, 2016. View at Publisher · View at Google Scholar
  74. S. Guo, M. Long, X. Li, S. Zhu, M. Zhang, and Z. Yang, “Curcumin activates autophagy and attenuates oxidative damage in EA.hy926 cells via the Akt/mTOR pathway,” Molecular Medicine Reports, vol. 13, no. 3, pp. 2187–2193, 2016. View at Publisher · View at Google Scholar · View at Scopus
  75. F. Les, J. M. Prieto, J. M. Arbonés-Mainar, M. S. Valero, and V. López, “Bioactive properties of commercialised pomegranate (Punica granatum) juice: antioxidant, antiproliferative and enzyme inhibiting activities,” Food and Function, vol. 6, no. 6, pp. 2049–2057, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. G. Terrazzano, M. Sica, C. Gianfrani et al., “Gliadin regulates the NK-dendritic cell cross-talk by HLA-E surface stabilization,” The Journal of Immunology, vol. 179, no. 1, pp. 372–381, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. F. Alfinito, G. Ruggiero, M. Sica et al., “Eculizumab treatment modifies the immune profile of PNH patients,” Immunobiology, vol. 217, no. 7, pp. 698–703, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. V. Barak, S. Birkenfeld, T. Halperin, and I. Kalickman, “The effect of herbal remedies on the production of human inflammatory and anti-inflammatory cytokines,” Israel Medical Association Journal, vol. 4, no. 11, pp. 919–922, 2002. View at Google Scholar · View at Scopus
  79. P. Dhasarathan, R. Gomathi, P. Theriappan, and S. Paulsi, “Immunomodulatory activity of alcoholic extract of different fruits in mice,” Journal of Applied Sciences Research, vol. 6, no. 8, pp. 1056–1059, 2010. View at Google Scholar · View at Scopus
  80. D. J. Buttle, J. M. Behnke, Y. Bartley et al., “Oral dosing with papaya latex is an effective anthelmintic treatment for sheep infected with Haemonchus contortus,” Parasites and Vectors, vol. 4, no. 1, article 36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. S. Halder, A. K. Mehta, and P. K. Mediratta, “Augmented humoral immune response and decreased cellmediated immunity by Aloe vera in rats,” Inflammopharmacology, vol. 20, no. 6, pp. 343–346, 2012. View at Publisher · View at Google Scholar · View at Scopus
  82. D. K. Kim, H. S. Lillehoj, S. H. Lee, S. I. Jang, E. P. Lillehoj, and D. Bravo, “Dietary Curcuma longa enhances resistance against Eimeria maxima and Eimeria tenella infections in chickens,” Poultry Science, vol. 92, no. 10, pp. 2635–2643, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. M. P. Barros, D. P. Marin, A. P. Bolin et al., “Combined astaxanthin and fish oil supplementation improves glutathione-based redox balance in rat plasma and neutrophils,” Chemico-Biological Interactions, vol. 197, no. 1, pp. 58–67, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. T. Olivry and P. Bizikova, “A systematic review of randomized controlled trials for prevention or treatment of atopic dermatitis in dogs: 2008–2011 update,” Veterinary Dermatology, vol. 24, no. 1, pp. 97–e26, 2013. View at Publisher · View at Google Scholar · View at Scopus
  85. T. Olivry, “A review of autoimmune skin diseases in domestic animals: I—superficial pemphigus,” Veterinary Dermatology, vol. 17, no. 5, pp. 291–305, 2006. View at Publisher · View at Google Scholar · View at Scopus
  86. D. W. Scott and M. Paradis, “A survey of canine and feline skin disorders seen in a university practice: Small Animal Clinic, University of Montréal, Saint-Hyacinthe, Québec (1987–1988),” The Canadian Veterinary Journal, vol. 31, no. 12, pp. 830–835, 1987. View at Google Scholar
  87. A. E. Jergens, F. M. Moore, J. S. Haynes, and K. G. Miles, “Idiopathic inflammatory bowel disease in dogs and cats: 84 cases (1987–1990),” Journal of the American Veterinary Medical Association, vol. 201, no. 10, pp. 1603–1608, 1992. View at Google Scholar · View at Scopus
  88. H. El-Gabalawy, L. C. Guenther, and C. N. Bernstein, “Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities,” Journal of Rheumatology, vol. 37, no. 85, pp. 2–10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. M. R. Shurin and Y. S. Smolkin, “Immune-mediated diseases: where do we stand?” Advances in Experimental Medicine and Biology, vol. 601, pp. 3–12, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. I. Chopra and M. Roberts, “Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance,” Microbiology and Molecular Biology Reviews, vol. 65, no. 2, pp. 232–260, 2001. View at Publisher · View at Google Scholar · View at Scopus